Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Feb;84(2):469–475. doi: 10.1111/j.1476-5381.1985.tb12931.x

The effects of meptazinol in comparison with pentazocine, morphine and naloxone in a rat model of anaphylactic shock.

P M Paciorek, M H Todd, J F Waterfall
PMCID: PMC1987277  PMID: 3978318

Abstract

The actions of meptazinol, pentazocine, morphine and naloxone on the cardiovascular changes accompanying anaphylactic shock were evaluated in ovalbumin-sensitized anaesthetized rats. Pretreatment with meptazinol and pentazocine prevented the fall in mean arterial pressure associated with antigen challenge, whereas morphine and naloxone attenuated but did not completely prevent, this change. None of the drugs significantly altered the antigen-induced decreases in heart rate. All the drugs partially reversed the fall in mean arterial pressure when given after antigen challenge although the activity of naloxone was less marked. Pretreatment with reserpine prevented the restoration of blood pressure by all drugs. Additional experiments with meptazinol showed that pretreatment with phentolamine prevented its pressor action. In pithed non-sensitized rats the frequency-pressor response curve to splanchnic stimulation was shifted to the left by meptazinol and shifted to the right by pentazocine, but the changes were small Morphine and naloxone had no significant effects. It was concluded that opioid mixed agonist-antagonists reverse the cardiovascular changes associated with anaphylactic shock. These effects appear to be mediated by facilitation of sympathetic neurotransmission.

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amir S. Opiate antagonists improve survival in anaphylactic shock. Eur J Pharmacol. 1982 May 7;80(1):161–162. doi: 10.1016/0014-2999(82)90194-7. [DOI] [PubMed] [Google Scholar]
  2. CAIRNIE A. B., KOSTERLITZ H. W., TAYLOR D. W. Effect of morphine on some sympathetically innervated effectors. Br J Pharmacol Chemother. 1961 Dec;17:539–551. doi: 10.1111/j.1476-5381.1961.tb01141.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CHASNOW E. A., SMALL H. S., HENRY J. H., PAPPER E. M., NAHAS G. G. THE EFFECT OF MORPHINE, MEPERIDINE, AND THIOPENTAL IN HYPOVOLEMIC SHOCK. Surgery. 1964 Apr;55:567–573. [PubMed] [Google Scholar]
  4. Curtis M. T., Lefer A. M. Protective actions of naloxone in hemorrhagic shock. Am J Physiol. 1980 Sep;239(3):H416–H421. doi: 10.1152/ajpheart.1980.239.3.H416. [DOI] [PubMed] [Google Scholar]
  5. Evans D. F., Foster G. E., Hardcastle J. D., Jonhson F., Wright J. W. The action of porcine glucagon on the motility of the canine duodenum and jejunum. Br J Pharmacol. 1982 Jun;76(2):245–252. doi: 10.1111/j.1476-5381.1982.tb09213.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FELDBERG W., PATON W. D. M. Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine liberators. J Physiol. 1951 Aug;114(4):490–509. doi: 10.1113/jphysiol.1951.sp004639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Faden A. I., Holaday J. W. Opiate antagonists: a role in the treatment of hypovolemic shock. Science. 1979 Jul 20;205(4403):317–318. doi: 10.1126/science.451606. [DOI] [PubMed] [Google Scholar]
  8. Faden A. I., Jacobs T. P., Feuerstein G., Holaday J. W. Dopamine partially mediates the cardiovascular effects of naloxone after spinal injury. Brain Res. 1981 Jun 1;213(2):415–421. doi: 10.1016/0006-8993(81)90246-8. [DOI] [PubMed] [Google Scholar]
  9. Gillespie J. S., Muir T. C. A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br J Pharmacol Chemother. 1967 May;30(1):78–87. doi: 10.1111/j.1476-5381.1967.tb02114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Holaday J. W., Faden A. I. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature. 1978 Oct 5;275(5679):450–451. doi: 10.1038/275450a0. [DOI] [PubMed] [Google Scholar]
  11. Huidobro-Toro J. P., Musacchio J. M. Naloxone reversal of insulin-induced hypotension in reserpine pretreated rats. Arch Int Pharmacodyn Ther. 1981 Jun;251(2):310–321. [PubMed] [Google Scholar]
  12. Lux W. E., Jr, Feuerstein G., Faden A. I. Thyrotropin-releasing hormone reverses experimental anaphylactic shock through non-endorphin-related mechanisms. Eur J Pharmacol. 1983 Jun 3;90(2-3):301–302. doi: 10.1016/0014-2999(83)90255-8. [DOI] [PubMed] [Google Scholar]
  13. Paciorek P. M., Todd M. H., Wyllie M. G. Restoration of mean arterial pressure in endotoxic shock by meptazinol. Contributions from lysosomal membrane stabilisation, opiate antagonism and noradrenaline release. Biochem Pharmacol. 1983 Mar 1;32(5):877–881. doi: 10.1016/0006-2952(83)90591-9. [DOI] [PubMed] [Google Scholar]
  14. Peters W. P., Johnson M. W., Friedman P. A., Mitch W. E. Pressor effect of naloxone in septic shock. Lancet. 1981 Mar 7;1(8219):529–532. doi: 10.1016/s0140-6736(81)92865-8. [DOI] [PubMed] [Google Scholar]
  15. Rashid S., Waterfall J. F. Cardiovascular actions of meptazinol in comparison with pentazocine and morphine. Gen Pharmacol. 1979;10(6):459–464. doi: 10.1016/0306-3623(79)90009-0. [DOI] [PubMed] [Google Scholar]
  16. Reynolds D. G., Gurll N. J., Vargish T., Lechner R. B., Faden A. I., Holaday J. W. Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock. Circ Shock. 1980;7(1):39–48. [PubMed] [Google Scholar]
  17. SANYAL R. K., WEST G. B. Anaphylactic shock in the albino rat. J Physiol. 1958 Aug 6;142(3):571–584. doi: 10.1113/jphysiol.1958.sp006037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stephens R. J., Waterfall J. F., Franklin R. A. A review of the biological properties and metabolic disposition of the new analgesic agent, meptazinol. Gen Pharmacol. 1978;9(2):73–78. doi: 10.1016/0306-3623(78)90002-2. [DOI] [PubMed] [Google Scholar]
  19. Tammisto T., Jättelä A., Nikki P., Takki S. Effect of pentazocine and pethidine on plasma catecholamine levels. Ann Clin Res. 1971 Feb;3(1):22–29. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES